Since anti-Gal is ubiquitously produced in large amounts in all humans who are not severely immunosuppressed, it was hypothesized that cancer patients may benefit from vaccination with lethally irradiated self-tumor cells or cell membranes engineered to present α-gal epitopes [52,53]. Here, GAL is linked to neoplasm.